A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Public ClinicalTrials.gov record NCT06911502. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) Vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy
Study identification
- NCT ID
- NCT06911502
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Celgene
- Industry
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Interventions
- Bendamustine Drug
- Cyclophosphamide Drug
- Doxorubicin Drug
- Golcadomide Drug
- Lenalidomide Drug
- Prednisone/Prednisolone Drug
- Rituximab Drug
- Vincristine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 27, 2025
- Primary completion
- Apr 23, 2028
- Completion
- Jul 30, 2030
- Last update posted
- May 19, 2026
2025 – 2030
United States locations
- U.S. sites
- 31
- U.S. states
- 17
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0225 | Birmingham | Alabama | 35205 | Not yet recruiting |
| Infirmary Cancer Care | Mobile | Alabama | 36607 | Recruiting |
| Alaska Oncology and Hematology | Anchorage | Alaska | 99508 | Recruiting |
| Local Institution - 0215 | Little Rock | Arkansas | 72205 | Not yet recruiting |
| City of Hope Comprehensive Cancer Center | Duarte | California | 91010 | Recruiting |
| UCSF Helen Diller Medical Center at Parnassus Heights | San Francisco | California | 94143 | Recruiting |
| Local Institution - 0008 | Jacksonville | Florida | 32256 | Not yet recruiting |
| Local Institution - 0214 | Tampa | Florida | 33606 | Not yet recruiting |
| Local Institution - 0217 | Tampa | Florida | 33612 | Not yet recruiting |
| Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital | Marietta | Georgia | 30060 | Recruiting |
| Southeastern Regional Medical Center | Newnan | Georgia | 30265 | Recruiting |
| Local Institution - 0240 | Arlington Heights | Illinois | 60005 | Not yet recruiting |
| Local Institution - 0253 | Iowa City | Iowa | 52242 | Not yet recruiting |
| Local Institution - 0243 | Waukee | Iowa | 50309 | Not yet recruiting |
| Local Institution - 0216 | Westwood | Kansas | 66205 | Not yet recruiting |
| Local Institution - 0218 | Lexington | Kentucky | 40536 | Not yet recruiting |
| Local Institution - 0023 | Baltimore | Maryland | 21201 | Not yet recruiting |
| Greater Baltimore Medical Center | Towson | Maryland | 21204 | Recruiting |
| Local Institution - 0145 | Boston | Massachusetts | 02114 | Not yet recruiting |
| Local Institution - 0244 | Boston | Massachusetts | 02215 | Not yet recruiting |
| Local Institution - 0247 | Boston | Massachusetts | 02215 | Not yet recruiting |
| Hattiesburg Clinic Hematology/Oncology | Hattiesburg | Mississippi | 39401-7233 | Recruiting |
| Local Institution - 0144 | Providence | Rhode Island | 02903 | Not yet recruiting |
| Texas Oncology - Central/South Texas | Austin | Texas | 78705 | Recruiting |
| Local Institution - 0212 | Fort Worth | Texas | 76104 | Not yet recruiting |
| Local Institution - 0230 | San Antonio | Texas | 78240 | Not yet recruiting |
| Texas Oncology - Northeast Texas | Tyler | Texas | 75702 | Recruiting |
| Local Institution - 0238 | Fairfax | Virginia | 22304 | Not yet recruiting |
| Hematology Oncology Associates of Fredericksburg | Fredericksburg | Virginia | 22408 | Recruiting |
| Blue Ridge Cancer Care | Roanoke | Virginia | 24014 | Recruiting |
| Local Institution - 0143 | Vancouver | Washington | 98684 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 129 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06911502, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 19, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06911502 live on ClinicalTrials.gov.